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Background: Promotion of healthy pregnancies has gained high priority in the Netherlands because of the
relatively unfavourable perinatal health outcomes. In response a nationwide study Healthy Pregnancy 4 All was
initiated. This study combines public health and epidemiologic research to evaluate the effectiveness of two
obstetric interventions before and during pregnancy: (1) programmatic preconception care (PCC) and (2) systematic
antenatal risk assessment (including both medical and non-medical risk factors) followed by patient-tailored
multidisciplinary care pathways. In this paper we present an overview of the study setting and outlines. We
describe the selection of geographical areas and introduce the design and outline of the preconception care
and the antenatal risk assessment studies.
Methods/design: A thorough analysis was performed to identify geographical areas in which adverse perinatal
outcomes were high. These areas were regarded as eligible for either or both sub-studies as we hypothesised
studies to have maximal effect there. This selection of municipalities was based on multiple criteria relevant to
either the preconception care intervention or the antenatal risk assessment intervention, or to both. The
preconception care intervention was designed as a prospective community-based cohort study. The antenatal
risk assessment intervention was designed as a cluster randomised controlled trial – where municipalities are
randomly allocated to intervention and control.
Discussion: Optimal linkage is sought between curative and preventive care, public health, government, and
social welfare organisations. To our knowledge, this is the first study in which these elements are combined.
Keywords: Cohort study, Randomized controlled trial, Preconception care, Antenatal care, Public health,
Epidemiology, Pregnancy, Neighbourhood, Care pathwayBackground
Perinatal mortality rates in the Netherlands are high and
decline slower than in other European countries [1-3].
Furthermore, an inequality in adverse perinatal outcomes
is seen as more risks and a higher risk load for adverse
outcomes were found for women living in socially de-
prived areas [4]. Population-based cohort studies, e.g., the
Generation R [5] and ABCD [6] studies have contrib-
uted to our knowledge of various health problems in
pregnancy and childhood and their lasting impact on* Correspondence: denktas@abd.eur.nl
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unless otherwise stated.health in later life. Studies using a large national Dutch
database (The Netherlands Perinatal Registry) showed
increased adverse pregnancy outcome in large urban
areas, in particular in deprived neighborhoods [7,8].
Analyses of this database provided recognition that four
specific morbidities precede perinatal mortality in 85%
of cases, the so-called ‘Big4’ morbidities [9,10]. These
are: congenital anomalies (list defined), preterm birth
(<37th week of gestation), small for gestational age
(SGA, birth weight <10th percentile for gestational age)
or low Apgar score (<7, 5 minutes after birth).
Taking prior research into account, a nationwide study
focusing on deprived areas with a higher than average peri-
natal mortality and morbidity rate was designed. Our strat-
egy was to perform a thorough epidemiological analysis tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have the highest impact in improving perinatal health.
Healthy Pregnancy 4 All
With the support of the Ministry of Health and Welfare
a nationwide study called ‘Healthy Pregnancy 4 All’
(HP4All), was initiated. Several municipal pilot studies
in the city of Rotterdam provided its framework [11].
The main objective of HP4All is to evaluate the effect-
iveness of the interventions and their associated prevent-
ive strategies in either the preconception period or the
antenatal period to reduce adverse pregnancy outcome.
Accordingly, two sub-studies are designed: a population-
based prospective cohort study focusing on the effective-
ness of customized preconception care (PCC) and a
systematic antenatal risk assessment score-card includ-
ing both medical and non-medical risk factors followed
by patient-tailored multidisciplinary care pathways.
The rationale of the PCC sub-study originates from in-
creasing evidence showing the critical influence of embry-
onic development and placentation during early pregnancy
on pregnancy outcome [12-14]. Risks influencing this early
pregnancy phase can be modified optimally in the precon-
ception period [14-16]. The Dutch Health Council recom-
mended (2007) to integrate general PCC in the health care
system [17]. The Minister of Health, however, advised to
evaluate the utilization and effectiveness of PCC for high
risk groups first, before collective reimbursement of PCC
in Dutch obstetric care would be (re)considered.
The second sub-study concerns a cluster randomized
controlled trial, focusing on the early detection of risks for
adverse pregnancy outcomes with a score card including
both medical and non-medical risks. The unique Dutch
system of obstetric care system has three risk-based levels
of care: primary care (indicated for low risk pregnancies
and deliveries, provided by independently practicing mid-
wives), and secondary/tertiary care (indicated for high risk
pregnancies, provided by obstetricians) [18]. As the level
of care depends on the distinction between low risk and
high risk pregnancies, antenatal risk assessment is an im-
portant part of Dutch obstetric care [18]. Although social
deprivation has been shown to contribute to adverse peri-
natal health in the Netherlands, standard risk assessment
does not include the assessment of non-medical risks
of perinatal health [4,7,19,20]. In addition, subsequent
patient-tailored pathways are lacking. Therefore, in the
new antenatal risk assessment tool (‘R4U score card’) both
medical and non-medical risk factors are explicitly taken
into account as part of the HP4All study.
The aim of this paper is to present an overview of the
HP4All study. Below, we first describe the selection of
geographical areas most eligible for the interventions.
Next we introduce the design of the preconception care
and the antenatal risk assessment sub-studies.Methods/design
Identification and selection of the eligible geographical
areas for the interventions
The first step was the identification of the geographical
units in which the aforementioned sub-studies would
preferably be carried out. We used a national Geographic
Information System (GIS) to divide The Netherlands into
62 municipalities, being the 50 municipalities with
> 70.000 inhabitants and the 12 provinces (excluding the
50 previously selected municipalities). The second step in-
volved the selection of municipalities in which to carry
out the sub-studies, based on multiple criteria which are
relevant to either the preconception care intervention or
broadened antenatal risk assessment.
Of the 50 cities with >70.0000 inhabitants, we selected
municipalities according to socio-demographic parameters
associated with high risk load (maternal age, parity, ethni-
city, and socioeconomic status) and perinatal outcome
data (overall ‘Big4’ and perinatal mortality prevalence).
Before the municipalities could be selected, specific pa-
rameters that make delivery of PCC or antenatal risk as-
sessment relevant were applied.
For the PCC sub-study these criteria were (1) propor-
tion of women having their first antenatal booking visit
at ≥14 weeks of gestational age, and prevalences of (2)
congenital anomalies and of (3) SGA. The moment of
the first antenatal booking is important because it is a
condition for timely intervention upon present risk fac-
tors. The effectiveness of these interventions is larger in
an early fetal stage. Congenital anomaly and SGA preva-
lences are considered to be indicative for a region’s peri-
conceptional health status.
For the antenatal risk assessment sub-study, additional
criteria were (1) overall perinatal mortality rates, (2) peri-
natal mortality amongst women with ‘Big4’ pregnancies
(‘case-fatality’), and (3) prevalence of SGA and prematur-
ity. For each specific indicator we present the absolute
rate, the standardised rate and the so-called inequality-
rate, the latter being expressed as the relative risk of the
outcome for low SES (socioeconomic status) pregnant
women compared to high SES pregnant women, after dir-
ect standardisation for maternal age, parity and ethnicity.
Standardisation is needed because a region with, e.g. a
high number of non-Western women or a high number of
teenage pregnancies will generally have a higher preva-
lence of adverse perinatal outcomes [21].
Data sources
The division of The Netherlands into 62 municipalities
was based on 4-digit postal codes areas. Data were pro-
vided by the Falk company (www.falk.nl), the National
Public Health Authority, and the Statistics Netherlands
organisation (CBS, www.cbs.nl). Information on socio-
economic status (SES, determined in 2006) per postal
Table 1 Demographic characteristics of the study
population by yes/no ‘G4-cities’ (the four largest cities)
with percentages in brackets
G4-cities NETHERLANDS
MINUS G4-CITIES
TOTAL
No. of pregnancies
during study period
245445 (100.0) 1338420 (100.0) 1583865 (100.0)
Parity
Primiparous 121592 (49.5) 607953 (45.4) 729545 (46.1)
Multiparous 123853 (50.5) 730467 (54.6) 854320 (53.9)
Ethinicity
Western 139786 (57.0) 1186772 (88.7) 1326558 (83.8)
Non-Western 105659 (43.0) 151648 (11.3) 257307 (16.2)
Maternal age
< 20 years 6987 (2.8) 19861 (1.5) 26848 (1.7)
20-24 years 34864 (14.2) 127013 (9.5) 161877 (10.2)
25-29 years 61354 (25.0) 395138 (29.5) 456492 (28.8)
30-34 years 85444 (34.8) 535927 (40.0) 621371 (39.2)
≥ 35 years 56796 (23.1) 260481 (19.5) 317277 (20.0)
Socioeconomic ‘status
score’
<p20 145367 (59.2) 254607 (19.0) 399974 (25.3)
p20-p80 58641 (23.9) 853074 (63.7) 911715 (57.6)
>p80 41437 (16.9) 230739 (17.2) 272176 (17.2)
Neighbourhood
Non-deprived 165658 (67.5) 1320392 (98.7) 1486050 (93.8)
Deprived 79787 (32.5) 18028 (1.3) 97815 (6.2)
Perinatal outcomes**
Congenital anomalies 5233 (2.1) 33159 (2.5) 38392 (2.4)
Preterm birth 15673 (6.4) 81646 (6.1) 97319 (6.1)
Small for gestational
age
27724 (11.3) 125175 (9.4) 152899 (9.7)
Apgar score <7 3385 (1.4) 14818 (1.1) 18203 (1.1)
(5 minutes after birth)
Any Big4** 50267 (20.5) 242697 (18.1) 292964 (18.5)
Fetal mortality† 1478 (0.6) 6718 (0.5) 8196 (0.5)
Intrapartum mortality 458 (0.2) 2126 (0.2) 2584 (0.2)
Neonatal mortality†† 761 (0.3) 3547 (0.3) 4308 (0.3)
Perinatal mortality‡ 2697 (1.1) 12391 (0.9) 15088 (1.0)
**Individual ‘Big4’ morbidities do not add up to ‘any Big4’.
as women can have >1 ‘Big4’ morbidity.
†From 22 weeks of gestational age.
††0–7 days postpartum.
‡Total of fetal, intrapartum and neonatal mortality.
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ning Office (SCP, www.scp.nl). Data on pregnancy and
perinatal outcome were derived from The Netherlands
Perinatal Registry (2000–2008). This database contains in-
formation of more than 97% of all pregnancies in The
Netherlands [21]. The data are routinely collected by 94%
of midwives, 99% of gynaecologists and 68% of paediatri-
cians including 100% of Neonatal Intensive Care Unit
paediatricians [21].
Table 1 shows the demographic characteristics of the
so-called ‘G4-cities’, i.e. the four largest cities: Amsterdam,
Rotterdam, The Hague, Utrecht, and the rest of the
Netherlands. Compared to the rest of The Netherlands,
the ‘G4’-cities have a larger proportion of non-Western
women (43% vs. 11.3%), more teenage pregnancies (2.8%
vs. 1.5%), and more women in low SES neighbourhoods
(59.2% vs. 19.0%). Considerably more women live in de-
prived neighbourhoods (32.5% vs. 1.3%) and the overall
adverse perinatal outcome is worse in ‘G4-cities’, as illus-
trated by a ‘Big4’ prevalence of 20.5% compared to 18.1%.
Perinatal mortality and ‘Big4’ prevalence
Figures 1 and 2 illustrate the geographical distribution
(50 municipalities and 12 provinces) of perinatal mortal-
ity rates, and the prevalence rate of ‘Big4’ (per 1,000), re-
spectively. Various shades of red represent the different
prevalence classes, the darker the shade the more preva-
lent the adverse outcome. The classes are based on the
distribution of the rates: the middle three classes com-
prise 95% (2 standard deviations) of the outcome levels;
the middle class comprises 68%. Both figures show large
geographical inequalities in adverse perinatal outcomes
on the national level.
Comparison municipalities
We additionally compared these outcomes across areas
after direct standardisation [22] for population differ-
ences by maternal age, parity, ethnicity, and SES. Stand-
ardisation is needed because a region with, e.g. a high
number of non-Western women or a high number of
teenage pregnancies will generally have a higher preva-
lence of adverse perinatal outcomes.
Tables 2 and 3 show the socio-demographic parameters
and the specific criteria for the PCC and the antenatal risk
assessment sub-studies. For each specific indicator we
present the absolute rate (ABS), the standardized rate
(STND) and the inequality-rate (INEQ, the relative risk of
the standardised outcome for low SES pregnant women
compared to high SES pregnant women) [8]. Next, to fa-
cilitate comparisons, we assigned decile scores to re-
gions, varying from one (the region is one of the 10%
areas with best outcomes) to 10 (the region belongs
to the 10% worst outcomes). The sum of the decile
scores for the various indicators by region is shown inthe last column (‘RANK’); higher scores imply unfavour-
able ranking. Decile scores were calculated the 10th
decile (10% with the most adverse outcomes), the 10th-
20th decile. Based on the sum of the decile scores for
Figure 1 Absolute prevalence of perinatal mortality per 1000 births.
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ities have the most adverse outcomes, i.e. 1. The Hague;
2. Rotterdam; 3. Eindhoven; 4. Amsterdam; 5. Schiedam;
6. Almere; 7. Delft; 8. Utrecht; 9. Maastricht; 10.
Tilburg; 11. Heerlen; 12. Arnhem; 13. Friesland. Ac-
cording to the sum of the decile score for the risk
assessment sub-study (Table 3) the following municipal-
ities show the most adverse outcomes: 1. The Hague; 2.
Amsterdam; 3. Rotterdam; 4. Arnhem; 5. Tilburg; 6.
Nijmegen; 7. Schiedam; 8. Utrecht; 9. Enschede; 10.
Spijkenisse; 11. Heerlen; 12. Vlaardingen; 13. Groningen;
14. Leeuwarden.
Additional to the identified municipalities, the prov-
ince of Friesland best qualified for the PCC sub-study
and the province of Groningen for the risk assessment
sub-study.
Final selection municipalities
After the epidemiological selection of the candidate mu-
nicipalities the list was first presented to the Ministry of
Health. The next step was to inform the Alderman andmunicipal health authorities about their perinatal
health status. They were invited to commit to the
HP4All study. Criteria to participate were: a) active
involvement by a local Policy Officer (>one day per
week for the duration of the study), b) local political
support for the study (e.g. financial support, involve-
ment in health related policy, local resources, in-
volvement of local networks).
The following municipalities agreed to participate (see
Figure 3): in the province of Groningen Appingedam/
Delfzijl/Menterwolde/Pekela and Groningen city, the
municipalities of Enschede, Nijmegen, Heerlen, Tilburg,
Schiedam, Utrecht, The Hague, Amsterdam, and Almere.
All municipalities decided to participate in both sub-
studies. As a separate municipal program on reducing
perinatal mortality was already being carried out in
Rotterdam5, this city was not selected for participation
in the HP4All study.
In these participating municipalities, general practi-
tioners, midwives, and obstetricians were approached for
provision of the interventions.
Figure 2 Absolute prevalence of ‘Big4’ morbidities per 1000 births.
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The preconception care sub-study
This sub-study is a prospective cohort that aims to
evaluate the effectiveness of individual Preconception
Care Consultations and the effectiveness of the employed
recruitment strategy for the PCC consultation services.
Preconception care consultations are delivered by primary
caregivers (General Practitioners and midwifes) in the
community. These consultations consist of two sessions.
Prior to the first session the woman fills in a questionnaire
(www.zwangerwijzer.nl). This questionnaire screens risk
factors across the following domains: background, lifestyle,
medical history, obstetric/gynecologic history, family,
work/environmental. Thus, risk factor screening is per-
formed in a uniform way before the consultation. During
the consultation a history is taken regarding the presence
of potential risk factors and a intervention plan is made
with the women/couple to reduce/eliminate risk factors.
Three months later a follow-up consultation is planned to
evaluate adherence to the intervention plan.
Uptake of individual PCC is known to be low. Thus
additional efforts seem necessary to promote uptake
of the consultations [23]. For this purpose a 4-armedrecruitment strategy is employed. Women are informed
about the PCC consultations by: (1) an invitational letter
from the municipal health service or municipality, (2) in-
vitational letter from the family doctor, (3) referral by
the youth health care service, (4) referral by a precon-
ception health educator.
The study population consists of women aged 18 –
41 years old. Participation is voluntary.
There are several primary outcomes. Firstly, the effect-
iveness of the PCC consultations in terms of behavioral
changes (use of folic acid supplements, smoking cessation,
cessation of alcohol consumption and illicit substances be-
sides individual risk factors (e.g. obesity). Secondly, the ef-
fectiveness of the recruitment strategy is assessed. We
address this effectiveness by measuring the extent to
which each recruitment arm results in visitation of the
PCC service and by the characteristics of women that
these recruitment strategies reach.
Women are enrolled in the cohort study after they
have made an appointment for the PCC consultation.
When they participate they are asked to fill in a ques-
tionnaire and consent to laboratory tests before each
visit to the PCC health service. Biomarkers are tested to
Table 2 Selection criteria* for the preconception care experiment with scoring in deciles; the higher deciles represent a
more likely qualification for inclusion
Demographics 1st antenatal
booking ≥14W
Congenital
anomalies
SGA Rank
# Cities %
PREG
AGE
<20
NW
ETHN
LOW
SES
ABS STND INEQ ABS STND INEQ ABS STND INEQ
1 Amsterdam 10 8 10 10 10 10 3 3 2 7 8 6 9 96
2 Rotterdam 10 10 10 10 10 10 3 6 7 4 10 9 6 105
3 Den Haag 9 10 10 10 10 10 2 9 8 4 10 9 8 109
4 Utrecht 9 3 10 6 10 10 4 10 10 7 3 2 7 91
5 Eindhoven 8 7 9 7 9 9 6 8 9 8 9 9 5 103
6 Tilburg 8 8 9 9 5 4 10 4 4 5 10 10 3 89
7 Almere 8 7 10 3 10 9 1 7 7 6 9 8 8 93
8 Groningen city 7 9 5 9 2 2 5 2 2 4 5 3 5 60
9 Breda 7 6 6 5 3 1 9 9 9 3 6 7 4 75
10 Nijmegen 7 5 6 9 3 3 9 4 5 6 8 8 6 79
11 Enschede 6 8 8 10 4 4 2 5 5 3 9 7 6 77
12 Apeldoorn 6 5 3 2 6 7 4 1 1 9 5 4 10 63
13 Haarlem 7 3 7 6 8 7 3 1 2 7 4 4 7 66
14 Arnhem 6 9 9 8 8 5 7 6 6 3 7 7 5 86
15 Zaanstad 6 4 8 6 7 7 1 2 3 2 5 4 8 63
16 Amersfoort 7 2 7 4 9 9 7 5 6 6 3 2 4 71
17 Haarlemmermeer 7 1 4 1 4 5 4 1 1 2 2 2 7 41
18 's-Hertogenbosch 5 3 3 4 1 2 10 9 9 4 8 8 4 70
19 Zoetermeer 5 6 8 3 1 1 6 4 4 1 7 6 10 62
20 Zwolle 6 7 3 4 2 3 7 2 1 7 2 1 10 55
21 Maastricht 4 9 4 6 4 3 10 10 10 10 10 10 1 91
22 Dordrecht 6 10 9 7 9 8 3 2 1 3 7 7 8 80
23 Leiden 5 4 7 6 8 8 6 8 7 10 6 5 3 83
24 Emmen 4 6 1 10 4 5 10 2 2 7 6 4 9 70
25 Ede 5 6 3 5 5 6 6 7 8 2 1 1 5 60
26 Venlo 3 7 8 7 3 2 8 6 6 5 9 10 1 75
27 Westland 4 1 1 1 5 7 6 10 10 8 1 1 10 65
28 Deventer 5 6 6 8 7 8 7 7 7 2 7 7 2 79
29 Delft 3 7 9 9 7 5 7 10 10 10 5 5 6 93
30 Sittard-Geleen 3 8 3 7 1 2 10 5 4 4 9 8 1 65
31 Leeuwarden 4 10 4 9 5 4 8 8 8 2 5 3 10 80
32 Alkmaar 4 4 6 5 6 6 8 5 5 10 2 2 2 65
33 Heerlen 2 10 5 10 3 4 8 10 10 3 10 10 2 87
34 Helmond 5 5 7 6 6 5 4 8 8 5 9 10 1 79
35 Hilversum 1 5 5 3 9 9 1 1 1 8 3 5 1 52
36 Súdwest Fryslân 3 5 1 8 2 2 9 2 2 10 1 1 3 49
37 Amstelveen 2 1 8 2 8 8 1 1 1 10 2 1 10 55
38 Hengelo 4 6 4 7 5 6 1 4 3 1 4 4 5 54
39 Purmerend 2 4 6 4 9 10 1 3 5 1 4 6 9 64
40 Roosendaal 2 5 9 1 2 1 8 9 9 8 8 10 1 73
41 Oss 2 2 4 3 1 1 7 5 4 9 10 10 2 60
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Table 2 Selection criteria* for the preconception care experiment with scoring in deciles; the higher deciles represent a
more likely qualification for inclusion (Continued)
42 Schiedam 1 10 10 10 10 10 2 7 6 4 10 9 7 96
43 Spijkenisse 1 9 7 4 3 2 5 3 3 1 6 9 4 57
44 Leidschendam-
Voorburg
2 2 7 3 8 7 5 5 4 9 3 5 5 65
45 Alphen a/d Rijn 1 2 5 1 4 4 9 7 8 1 4 4 6 56
46 Almelo 3 8 5 8 2 3 1 1 1 9 7 6 1 55
47 Vlaardingen 1 8 10 5 7 4 8 6 5 9 8 8 4 83
48 Gouda 3 3 8 8 3 1 9 1 3 3 4 3 3 52
49 Middelburg 1 9 4 7 6 6 4 8 6 6 4 3 3 67
50 Vlissingen 1 10 6 5 8 6 5 6 8 1 8 9 3 76
# PROVINCES
51 Groningen 8 7 2 9 7 9 5 3 2 8 5 6 7 78
52 Friesland 9 4 1 8 9 9 3 10 10 8 2 3 9 85
53 Drenthe 9 3 1 5 6 8 6 4 4 2 3 5 8 64
54 Overijssel 9 1 1 2 5 7 2 3 3 6 1 2 9 51
55 Gelderland 10 2 2 2 1 3 3 10 9 9 2 3 6 62
56 Utrecht 10 1 3 1 2 3 5 9 9 5 1 1 7 57
57 Noord-Holland 10 1 2 2 7 8 2 6 6 5 1 1 8 59
58 Zuid-Holland 10 2 2 1 4 5 4 8 7 7 1 2 9 62
59 Zeeland 8 3 1 3 10 10 2 4 5 1 3 5 4 59
60 Noord-Brabant 10 1 2 1 1 1 9 7 7 5 6 7 2 59
61 Limburg 9 4 2 2 1 1 10 9 10 6 7 8 2 71
62 Flevoland 8 9 5 4 6 6 6 3 3 9 6 6 7 78
*‘% PREG’: % pregnant women in the general population/‘AGE <20’: % teenage pregnancies/‘PRIMI’: % primiparous women/‘NW ETHN’: % non-Western pregnant
women/‘LOW SES’: % women in neighbourhoods with a socioeconomic status score < p20/‘ABS’: Absolute %/‘STND’: Standardised %/‘INEQ’: Inequality as
measured by the relative risk of prevalences between women from neighbourhoods with socioeconomic status score < p20 compared to > p80.
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(erythrocyte folate, %carbohydrate transferrin (CDT), serum
cotinine levels and urinary drug tests). Furthermore an-
thropometric measurements are collected at these two
visits by the PCC provider. This data collection provides
data for pre- and post-measurements regarding PCC be-
haviors. Characteristics of women that visit the peer edu-
cation sessions are measured by questionnaires.
The antenatal risk assessment sub-study
In this cluster randomised trial (Trial registration: Dutch
Trial Registry: NTR-3367) midwifery practices in partici-
pating municipalities (‘clusters’) were randomly assigned
to either the use of a score card (‘R4U’) based antenatal
risk assessment, care pathways and multidisciplinary
consultation (intervention group) or conventional risk
assessment (control group).
The 70-item ‘R4U’ score card consists of six risk do-
mains (social status, ethnicity, care, lifestyle, medical
history and obstetric history). Corresponding care pathwaysto both medical and non-medical services will support
health care professionals to encounter complex (non-)
medical risk factors. A predefined weighted sum risk
threshold, based on weighted single risk factors, is de-
rived from the ‘R4U’ score card. If a pregnant woman’s
individual sum risk score exceeds the threshold, her
case will be assessed in a multidisciplinary setting with
community midwives, obstetricians, and other care
providers.
Score card based systematic risk assessment will be
performed with the ‘R4U’ score card at the first antenatal
booking visit followed by (provided that informed con-
sent is given), if necessary, a specific referral to, e.g. a
higher level obstetric care (gynaecologist), or psycho-
social care in case of medical or non-medical high risk
using risk-specific care pathways. Additionally, these
women at increased risk will be reviewed in a multidis-
ciplinary team of caregivers concerning tailored ante-
natal care. We aim to assess 20% of all pregnant women
in this multidisciplinary setting.
Table 3 Selection criteria* for the risk selection experiment with scoring in deciles; the higher deciles represent a more
likely qualification for inclusion
Demographics Perinatal
mortality/all
women
Perinatal
mortality/Big4
morbidities
Perinatal
mortality/start
labour in
primary care
Rank
# Cities %
PREG
AGE
<20
PRIMI NW
ETHN
LOW
SES
ABS STND INEQ ABS STND INEQ ABS STND INEQ
1 Amsterdam 10 8 10 10 10 8 6 9 8 7 7 7 5 8 113
2 Rotterdam 10 10 7 10 10 10 10 3 6 7 3 10 9 5 110
3 Den Haag 9 10 7 10 10 9 8 7 6 7 4 10 8 9 114
4 Utrecht 9 3 9 10 6 9 9 2 9 10 2 7 6 5 96
5 Eindhoven 8 7 9 9 7 5 5 4 2 2 2 9 8 6 83
6 Tilburg 8 8 7 9 9 8 8 6 4 5 8 9 9 3 101
7 Almere 8 7 4 10 3 8 10 3 5 8 3 6 7 7 89
8 Groningen 7 9 10 5 9 7 9 1 8 9 3 2 1 7 87
9 Breda 7 6 6 6 5 3 4 7 2 4 6 7 8 3 74
10 Nijmegen 7 5 8 6 9 10 10 4 10 10 2 6 6 7 100
11 Enschede 6 8 5 8 10 9 9 4 8 6 3 9 8 3 96
12 Apeldoorn 6 5 4 3 2 8 8 8 9 8 8 3 4 10 86
13 Haarlem 7 3 9 7 6 4 6 8 5 6 9 3 2 7 82
14 Arnhem 6 9 10 9 8 9 4 9 9 6 8 5 2 8 102
15 Zaanstad 6 4 6 8 6 2 1 1 2 1 4 5 6 4 56
16 Amersfoort 7 2 6 7 4 10 10 5 10 10 7 1 1 8 88
17 Haarlemmermeer 7 1 5 4 1 4 3 7 7 6 7 1 1 6 60
18 's-Hertogenbosch 5 3 10 3 4 6 5 3 4 4 5 6 7 5 70
19 Zoetermeer 5 6 6 8 3 1 1 2 1 1 1 6 7 10 58
20 Zwolle 6 7 6 3 4 6 2 5 8 4 2 4 1 10 68
21 Maastricht 4 9 8 4 6 8 7 8 3 2 6 10 9 6 90
22 Dordrecht 6 10 4 9 7 2 1 3 2 1 5 7 4 10 71
23 Leiden 5 4 10 7 6 4 2 9 3 2 9 4 5 3 73
24 Emmen 4 6 4 1 10 2 2 1 3 3 1 8 6 10 61
25 Ede 5 6 1 3 5 7 4 9 9 5 10 1 3 2 70
26 Venlo 3 7 5 8 7 3 2 10 3 1 10 10 10 2 81
27 Westland 4 1 1 1 1 1 2 8 1 1 8 8 7 9 53
28 Deventer 5 6 6 6 8 9 9 3 7 5 4 9 10 3 90
29 Delft 3 7 8 9 9 1 1 5 1 1 1 10 10 8 74
30 Sittard-Geleen 3 8 9 3 7 3 1 7 1 1 9 9 9 1 71
31 Leeuwarden 4 10 9 4 9 5 5 10 5 5 10 5 5 5 91
32 Alkmaar 4 4 7 6 5 2 2 10 4 3 10 3 4 1 65
33 Heerlen 2 10 10 5 10 7 8 6 1 2 8 10 10 4 93
34 Helmond 5 5 4 7 6 5 4 8 4 3 10 8 8 2 79
35 Hilversum 1 5 10 5 3 7 5 2 10 8 6 3 3 4 72
36 Súdwest Fryslân 3 5 2 1 8 7 7 10 10 10 10 1 1 7 82
37 Amstelveen 2 1 3 8 2 1 1 10 7 5 9 1 1 10 61
38 Hengelo 4 6 3 4 7 5 7 5 6 6 7 4 4 4 72
39 Purmerend 2 4 8 6 4 2 3 9 5 4 9 7 9 5 77
40 Roosendaal 2 5 5 9 1 2 5 2 1 2 5 9 10 1 59
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Table 3 Selection criteria* for the risk selection experiment with scoring in deciles; the higher deciles represent a more
likely qualification for inclusion (Continued)
41 Oss 2 2 5 4 3 3 4 7 1 2 7 8 7 6 61
42 Schiedam 1 10 9 10 10 10 10 9 6 4 8 5 1 4 97
43 Spijkenisse 1 9 8 7 4 10 8 6 9 8 4 6 7 7 94
44 Leidschendam-
Voorburg
2 2 7 7 3 1 1 10 4 3 10 2 3 8 63
45 Alphen a/d Rijn 1 2 8 5 1 10 10 1 10 10 5 4 3 5 75
46 Almelo 3 8 3 5 8 1 3 2 2 5 1 6 6 1 54
47 Vlaardingen 1 8 7 10 5 7 10 3 6 10 3 10 10 2 92
48 Gouda 3 3 1 8 8 6 3 10 7 6 9 2 2 3 71
49 Middelburg 1 9 1 4 7 1 3 1 3 4 2 2 2 2 42
50 Vlissingen 1 10 4 6 5 6 9 1 4 7 1 8 10 1 73
# PROVINCES
51 Groningen 8 7 3 2 9 9 8 6 10 9 6 5 5 4 91
52 Friesland 9 4 2 1 8 10 9 5 9 9 4 4 6 9 89
53 Drenthe 9 3 2 1 5 6 6 2 8 8 2 4 5 9 70
54 Overijssel 9 1 1 1 2 5 7 4 8 9 1 1 3 9 61
55 Gelderland 10 2 1 2 2 5 6 4 5 7 4 3 4 6 61
56 Utrecht 10 1 2 3 1 4 5 4 6 7 3 3 4 6 59
57 Noord-Holland 10 1 3 2 2 4 6 7 7 9 6 1 2 8 68
58 Zuid-Holland 10 2 2 2 1 4 6 1 5 8 1 2 2 9 55
59 Zeeland 8 3 2 1 3 8 7 8 10 10 5 2 3 1 71
60 Noord-Brabant 10 1 3 2 1 3 3 6 3 3 7 7 8 2 59
61 Limburg 9 4 5 2 2 3 4 5 2 3 6 8 9 1 63
62 Flevoland 8 9 1 5 4 6 7 6 7 9 5 5 5 10 87
*‘% PREG’: % pregnant women in the general population/‘AGE <20’: % teenage pregnancies/‘PRIMI’: % primiparous women/‘NW ETHN’: % non-Western pregnant
women/‘LOW SES’: % women in neighbourhoods with a socioeconomic status score < p20/‘ABS’: Absolute %/‘STND’: Standardised %/‘INEQ’: Inequality as
measured by the relative risk of prevalences between women from neighbourhoods with socioeconomic status score < p20 compared to > p80.
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sonal instructions in planned sessions by the project
team for the practical use of the web-based ‘R4U’ score
card. Besides, an e-learning program is available for all
caregivers. The project team has developed 28 templates
of care pathways for all risk factors in the ‘R4U’ score
card. Together with local healthcare professionals in
perinatal care, municipal services, community health ser-
vices, and other services, these templates will be adapted
in organised meetings to local setting, taking the avail-
ability of local facilities, agreements, and guidelines into
consideration.
Pregnant women’s risk status in the control group is
assessed conventionally, i.e. according to the elaborate
so-called ‘List of Obstetric Indications’ (in Dutch: Verlos-
kundige Indicatie Lijst) [24] which lists all conventional
(>140) high risk indications (for referral or consultation).
In each control municipality care ‘as usual’ will be pro-
vided until 700 participants have been included or until
2/3 of the study period (2 years) has passed. After thatmoment, the implementation of the risk assessment
intervention will start.
Primary outcomes are the prevalence of preterm birth
and SGA, and the efficacy of ‘R4U’ implementation
(measured by the number of ‘R4U’ score cards com-
pleted by the health care professional against the num-
ber of booking visits, the development and use of care
pathways following ‘R4U’ scores, actual performed multi-
disciplinary consultations, and patient and healthcare
professional satisfaction).Organisation and time schedule
The study is rolled out by the national HP4ALL staff of
the Erasmus Medical Center in Rotterdam and by the
local HP4ALL project managers. The staff consists of 2
junior researchers, research assistants and 2 project
managers (1 for each sub-study) and 2 program direc-
tors. The local project managers are either allocated
from the municipality or from the municipal health
Figure 3 Participating municipalities in the ‘Healthy Pregnancy 4 All’ project.
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the two sub studies is presented in the specific design
papers.
The HP4All study was initiated in April 2011. The
HP4ALL research team was organised by May 2011. Mu-
nicipalities had committed to participation in September
2011. Within the municipalities local health care providers
eligible to participation in the sub-studies were invited to
participate as of November 2011. At time of writing, the
study is ongoing.
Ethical considerations
The two The HP4All sub-studies have been approved by
the Institutional Board Review of the Erasmus Medical
Centre Rotterdam (Preconception Care sub-study: MEC
2012–425; Antenatal risk assessment trial: MEC 2012–
322). Participants in both studies will receive written
and oral information about the study after which in-
formed consent will be obtained. Participation in either
sub-study is voluntary and no extra incentives will be
provided. Health care providers participating in both
studies do not receive incentives. However in the PCCsub-study, providers will receive reimbursement from
the HP4All project, as PCC consultations are currently
not covered by (most) health care insurances.
Discussion
In this study we described the set-up of the ‘Healthy
Pregnancy 4 All’ study in which high perinatal risk re-
gions are targeted with two interventions based on pre-
conception care and antenatal care. The foundation of
this study lies in the scientific and systematic analysis of
the perinatal health problem in the Netherlands. The
study meets the current evidence to intervene early (be-
fore or in pregnancy) upon risk factors associated with
these perinatal health outcomes. By selection of geo-
graphical areas, the study will intervene in potentially
high risk populations that potentially will benefit the
most. We hypothesise that both strategies will contribute
to the promotion of perinatal health. In this project, op-
timal linkage is sought between curative and preventive
care, public health, government, and social welfare orga-
nisations. To our knowledge, this is the first study in
which these elements are combined.
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